Amarin's AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment and Randomization

- Trial Guidance Positively Updated -
DUBLIN, Ireland and MYSTIC, Conn., Aug. 10
/PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ:AMRN)
, a clinical-stage biopharmaceutical company with a focus on
cardiovascular disease, today announced...

...

More on Sciencestage.com

    More on Wikipedia

      More on answers.yahoo.com

        More on Pubmed

          More on Answers.com